Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
NCT01246739 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2024-04-10
Summary
Incidental findings of adrenal tumours,"incidentalomas", occur in 1-5 % in the general population and 10-25 % of these patients will exhibit biochemical mild hypercortisolism. Although the patients do not have clinical signs of classical Cushing's syndrome, they have an increased risk for hypertension, dyslipidemia, diabetes mellitus, osteoporosis and obesity.
The hypothesis of the study is, that surgery of the adrenal adenoma responsible for the increased secretion of cortisol, will in part cure or ameliorate the metabolic syndrome.
Conditions
- Adrenal Tumour With Mild Hypercortisolism
Interventions
- PROCEDURE
-
Adrenalectomy
Adrenalectomy (open or laparoscopic)
Sponsors & Collaborators
-
Region Skane
lead OTHER
Principal Investigators
-
Anders OJ Bergenfelz, MD, PhD · Department of Surgery, Skåne University Hospital, Lund, Sweden
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2024-02-29
- Completion
- 2024-02-29
Countries
- Denmark
- Norway
- Sweden
Study Locations
More Related Trials
-
Cushing's Syndrome Before and After Treatment (CORRECT)
NCT05521529 ·Status: RECRUITING
-
Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)
NCT04840693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma
NCT03145285 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-term Cardiovascular Risk in Cured Cushing's Patients
NCT00881283 ·Status: TERMINATED
-
Cushing's Disease Complications
NCT02568982 ·Status: COMPLETED
-
Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure
NCT01847690 ·Status: UNKNOWN ·Phase: PHASE2
-
Hydrocortisone Use During Peri-operation for Pituitary Adenomas
NCT04621565 ·Status: UNKNOWN ·Phase: NA
-
Peri-Operative Steroid Management in Patients
NCT02084134 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Acute Cortisol Withdrawal in Adrenal Failure
NCT00442390 ·Status: COMPLETED ·Phase: NA
-
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
NCT03760835 ·Status: RECRUITING ·Phase: PHASE4
-
Hair Cortisol and Cushing's Disease
NCT04201444 ·Status: COMPLETED ·Phase: NA
-
Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
NCT00647179 ·Status: COMPLETED
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
NCT00921609 ·Status: COMPLETED
-
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
NCT00500227 ·Status: COMPLETED
-
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
NCT03831958 ·Status: RECRUITING
-
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
NCT00612066 ·Status: TERMINATED ·Phase: PHASE2
-
Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
NCT05797558 ·Status: RECRUITING ·Phase: NA
-
The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases
NCT03575247 ·Status: COMPLETED
-
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
NCT00422201 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
NCT04339751 ·Status: WITHDRAWN ·Phase: PHASE2
-
Glucocorticoid Treatment in Addison's Disease
NCT01063569 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
NCT01422733 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.
NCT01862380 ·Status: UNKNOWN ·Phase: NA
-
Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery
NCT05149495 ·Status: UNKNOWN
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
NCT07335315 ·Status: RECRUITING